Delivery Order SPE2DB20D9759-SPE2DB25FD5LG

Award Date 1/23/25
Potential Completion Date 1/24/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $18,376.12 award is for the supply of the medication ADVAIR HFA 115-21 MCG INHALER 12GM. The award is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA through the SPE2DB program, which allows the DLA to place delivery orders for a wide range of...
This firm fixed-price delivery order for $1,239.58 was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB24 indefinite delivery contract. The order is for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM, a branded pharmaceutical product. This delivery order is part of DMS Pharmaceutical Group's larger $499,999,999 IDC with the DLA, which allows the agency to issue firm fixed-price orders for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $13,743.12, is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM medical supplies. The contract has no set-aside designation and is a firm fixed-price delivery order with an ultimate completion date of September 26, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $1,562.04 for the supply of pharmaceutical products, including Advair HFA 115-21 MCG inhalers. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is part of the SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999 that runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the provision of Advair HFA 115-21 MCG Inhaler 12GM. The $4,157.10 contract has a completion date of June 6, 2024 and is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, valued at...
This firm fixed-price delivery order award to DMS Pharmaceutical Group Inc., a woman-owned small business, is valued at $2,403.36. The award was made by the Defense Logistics Agency (DLA) under the SPE2DB program, a $499,999,999 indefinite delivery contract that allows the DLA to issue delivery orders for a wide range of pharmaceutical items to support the medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. This delivery order is for 4565662626 ADVAIR HFA...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) as a delivery order under the SPE2DB program. The $11,513.36 firm fixed-price contract is for the supply of Advair HFA 115-21 MCG inhalers, a specialized pharmaceutical product used to treat respiratory conditions. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a federal delivery order contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,708.01 firm fixed price contract is for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM, a prescription pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,928.42, is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a respiratory medication, to support federal healthcare programs. The contract is a firm fixed-price delivery order placed under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,454.81 contract is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a respiratory medication, with a period of performance through January 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
  • SPE2DB20D9759
    Indefinite Delivery Contract
  • SPE2DB20D9759-SPE2DB25FD5LG
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,715.40, is for the delivery of ADVAIR HFA 230-21 MCG INHALER 8GM, a specialized pharmaceutical product, to support the medical supply needs of military health facilities.

The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure this direct federal award. Additionally, DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain.

Generated 4/24/25, 10:06 AM